Pt Indofarma Tbk

Pt Indofarma Tbk is a prominent pharmaceutical company based in Indonesia, engaged in the manufacturing and distribution of a wide array of pharmaceutical products. Established in 1918, this company plays a significant role in the healthcare sector by producing medication for both domestic consumption and export. Its product portfolio includes prescription drugs, over-the-counter medications, and a variety of healthcare supplements and medical devices. Pt Indofarma Tbk supports the Indonesian government's initiatives in health by supplying affordable and essential medicines that cater to the needs of the public. The company operates several manufacturing facilities, adhering to stringent quality standards and regulations to ensure safety and efficacy in its offerings. Through strategic collaborations and an extensive supply chain network, Pt Indofarma Tbk significantly impacts sectors such as healthcare services, medical research, and public health policy. Its commitment to innovation and sustainability within the pharmaceutical industry positions the company as a vital entity in addressing health issues and improving the overall well-being of communities. This enhances its status within the Indonesian stock market, attracting interests from healthcare-focused investors and stakeholders.